FDA Clears IND for Kinnate Biopharma's RAF Inhibitor KIN-2787

Retrieved on: 2021-05-18 14:20:00

Tags for this article:

Click the tags to see associated articles and topics

FDA Clears IND for Kinnate Biopharma's RAF Inhibitor KIN-2787. View article details on hiswai:

Excerpt

NEW YORK – Kinnate Biopharma on Monday said that the US Food and Drug Administration has cleared an investigational new drug application for ...

Article found on: www.precisiononcologynews.com